Breakthrough MS treatment doesn't reach US patients EurekAlert! Wed, 04 Apr 2007 4:08 PM PDT Many US multiple sclerosis (MS) patients aren't receiving the latest drug therapies, according to research published in the online journal BMC Medicine. Immunomodulatory agents (IMAs) could slow the progress of the disease, but are only prescribed in a minority of cases, and mostly by neurologists.

First Centre of Its Kind in UK Opens in Region RedNova Thu, 05 Apr 2007 6:47 AM PDT By Barry Nelson THE first immunotherapy

Legislature Tweaks Med Pot Law KOIN News 6 Portland Thu, 05 Apr 2007 8:30 AM PDT OLYMPIA, Wash. - The Washington House passed a measure clarifying the state's medical marijuana law and addressing supply issues. But medical marijuana advocates and patients opposed to the measure argue it does nothing to help them.

Partnership for Prescription Assistance Celebrates Two Year Anniversary; Helps 3.6 Million Uninsured Patients Across ... RedNova Thu, 05 Apr 2007 9:01 AM PDT WASHINGTON, April 5 /PRNewswire/ -- Reaching a

Texas Institute for Genomic Medicine Will Supply Myelin Repair Foundation With Knockout Research Mice Throughout North ... RedNova Wed, 04 Apr 2007 11:01 AM PDT The Texas Institute for Genomic Medicine (TIGM) has entered into an agreement with the Myelin Repair Foundation to supply up to 15 pair of genetically altered mice over the next 12 months for collaborative research in the U.S.

Allergy/autoimmunity link found
UPI Wed, 04 Apr 2007 11:43 AM PDT
A link between allergic diseases like eczema, and autoimmune diseases has been found by scientists at the University of Washington in Seattle.